Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.30 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.30 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29957667 | 1.00 | KDM4E (0.33) | KDM4ETRPV4ENPP2ALDH1A1HPGD | |
| SCHEMBL29991689 | 0.84 | TRPV4 (0.33) | KDM4ETRPV4ENPP2ALDH1A1HPGD | |
| SCHEMBL19924663 | 0.84 | TRPV4 (0.33) | KDM4ETRPV4ENPP2ALDH1A1HPGD | |
| SCHEMBL25515254 | 0.81 | L3MBTL1 (0.34) | KDM4EENPP2ALDH1A1HSD17B10 | |
| SCHEMBL29170430 | 0.78 | ENPP2 (0.40) | KDM4EENPP2ALDH1A1HPGD | |
| SCHEMBL31198326 | 0.78 | ENPP2 (0.40) | KDM4EENPP2ALDH1A1HPGD | |
| SCHEMBL21852703 | 0.78 | — | — | |
| SCHEMBL29953053 | 0.76 | KDM4E (0.44) | KDM4ETRPV4ENPP2ALDH1A1HPGD | |
| SCHEMBL4966189 | 0.76 | KDM4E (0.44) | KDM4ETRPV4ENPP2ALDH1A1HPGD | |
| SCHEMBL186689 | 0.75 | TRPV4 (0.42) | KDM4ETRPV4ALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391668-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-08-19 | — | — | US | disclosed |
| CN-110249031-B | Organic molecules, in particular for organic optoelectronic devices | 三星显示有限公司 | 2023-12-05 | — | — | CN | disclosed |
| US-11825743-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| EP-3585777-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2023-05-10 | — | — | EP | disclosed |
| US-20220396565-A1 | NOVEL HETEROCYCLIC COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2022-12-15 | — | — | US | disclosed |
| US-11492344-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-11-08 | — | — | US | disclosed |
| US-11456426-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-09-27 | — | — | US | disclosed |
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| EP-3543230-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2021-05-05 | — | — | EP | disclosed |
| EP-3580300-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-10-21 | — | — | EP | disclosed |
| EP-2776396-A2 | HETEROARYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE | F.HOFFMANN-LA ROCHE AG (CH) | 2014-09-17 | — | — | EP | disclosed |
| US-20130102600-A1 | Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease | F. HOFFMANN-LA ROCHE LTD (CH) | 2013-04-25 | — | — | US | disclosed |
| US-20130102601-A1 | Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease | F. HOFFMANN-LA ROCHE LTD (CH) | 2013-04-25 | — | — | US | disclosed |
| WO-2013057253-A1 | PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2013-04-25 | — | — | WO | disclosed |
| WO-2013057251-A2 | HETEROARYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2013-04-25 | — | — | WO | disclosed |
| US-7776458-B2 | Used for forming an organic layer of the organic electroluminescent device, can emit light in the wavelength range of 400-650 nm, and induce white electroluminescence when combined with green or red luminescent materials; heat resistance; highly efficient Used for forming phospholuminescence; OLEDs | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-08-17 | — | — | US | disclosed |
| US-7678473-B2 | Organometallic complex and organic electroluminescent device using the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-03-16 | — | — | US | disclosed |
| US-7601438-B2 | Cyclometalated transition metal complex and organic electroluminescent display device using the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-10-13 | — | — | US | disclosed |
| US-20060172150-A1 | Organometallic complex and organic electroluminescent device using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2006-08-03 | — | — | US | disclosed |
| US-20060078760-A1 | Cyclometalated transition metal complex and organic electroluminescent display device using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2006-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102601-A1 | Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease | TPMT, TYMP, HPRT1 | KDM4E 3487/4885TRPV4 562/4885ENPP2 1221/4885 |
| US-11492344-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OCIAD2, OR51E2 | KDM4E 4433/4885TRPV4 374/4885ENPP2 4293/4885 |
| US-11825743-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OCIAD2 | KDM4E 4620/4885TRPV4 243/4885ENPP2 4083/4885 |
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OR51E2, OCIAD2 | KDM4E 4619/4885TRPV4 200/4885ENPP2 4036/4885 |
| US-20220396565-A1 | NOVEL HETEROCYCLIC COMPOUNDS | MRPL21, F12, MRPS34 | KDM4E 3538/4885TRPV4 2837/4885ENPP2 3226/4885 |
| US-20060078760-A1 | Cyclometalated transition metal complex and organic electroluminescent display device using the same | L1CAM, PDCD2L, MAP1LC3C | KDM4E 3014/4885TRPV4 444/4885ENPP2 2937/4885 |
| US-11456426-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OCIAD2 | KDM4E 4619/4885TRPV4 200/4885ENPP2 4036/4885 |
| US-12391668-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | SLC25A21, SLCO4C1, SLC18A1 | KDM4E 955/4885TRPV4 74/4885ENPP2 4314/4885 |
| US-20130102600-A1 | Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease | FAH, SLC10A1, OAT | KDM4E 3710/4885TRPV4 3108/4885ENPP2 984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.